Pricing

  For pricing information, USA customers sign in.
  Outside USA? Please contact your distributor for pricing.

Specifications

Major constituent of plaques and tangles that occur in Alzheimer’s disease (AD) patients
Catalog #	A2275-74F
	See A2275-74F1 for antisense, inactive peptide.
Sequence (linear)	H2N-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH
Amino Acid Analysis	Confirms expected sequence
Storage and Stability	Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Formula	C203H311N55O60S
Molecular Weight	4514.10
Source	Synthetic
Purity	~80-90% by HPLC analysis
Concentration	As reported
Form	Supplied as a lyophilized powder.
Important Note	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.